OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Tag Archives: cancer

Has A.P. Pharma, Inc. (OTCBB: APPA) Done Enough to Ease FDA Concerns Over Lead Drug Candidate?

It is getting close to crunch time for A.P. Pharma, Inc. (OTCBB: APPA) as the specialty pharmaceutical company’s FDA assigned Prescription Drug User Fee Act (PDUFA) action date of March 27, 2013 is drawing near and the future of their … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

Can Inovio Pharmaceuticals, Inc. (AMEX: INO) Realize Potential with Multiple Synthetic Vaccines for Wide Range of Medical Issues?

After starting the month of November strong with a share price that hit 0.7200 Inovio Pharmaceuticals, Inc. (AMEX: INO) hit a snag and slipped as low as 0.4400 but the biotechnology company has been posting some pretty impressive numbers of … Continue reading

Posted in AMEX, Articles | Tagged , , , , , , , , , | Leave a comment

BSD Medical Corporation (NASDAQ: BSDM) Reports Significant Sales Spike but is it a Difference Maker?

BSD Medical Corporation (NASDAQ: BSDM) delivered some positive news on Tuesday, announcing that they had seen a 391% increase in sales for their MicroThermX Microwave Ablation System product line for September 2012, as compared to September 2011 with their disposable … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , | Leave a comment

Does CytoCore, Inc. (OTCBB: CYOE) Stand a Chance as a Biomolecular Diagnostics Company?

For those investors who loaded up on CytoCore, Inc. (OTCBB: CYOE) prior to Thursday’s opening then yesterday must have played out like a dream as the biomolecular diagnostics company engaged in the design, development, and commercialization of cost-effective screening systems … Continue reading

Posted in Uncategorized | Tagged , , , , , , | Leave a comment

How Much Longer Can Cannabis Science Inc. (OTCBB: CBIS) Continue Down This Path?

Will it ever end for Cannabis Science Inc. (OTCBB: CBIS)? Can a company that has generated less than $150,000 in earned revenues while racking up an accumulated deficit in excess of $70.5 million during their six-plus years of operation really … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | Leave a comment

Is Genetic Technologies Ltd. (NASDAQ: GENE) Positioned for Growth with Breast Cancer Risk Test?

Genetic Technologies Ltd. (NASDAQ: GENE) has put together a staggering day of growth on Wednesday as shares have jumped from a Tuesday close of 3.12 up to a high of 4.28 today with trading volume already topping the 2.2 million … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , | Leave a comment

Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) Can’t Shake Investor Skepticism Despite Positive Results Tie to Lead Cancer Product

There appears to be no end in sight for the volatility surrounding Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) as shares of the biopharmaceutical company continue experience dramatic shifts in price. Activity on Tuesday has further displayed this volatility as PPHM bounced … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , | Leave a comment

Is Northwest Biotherapeutics (OTCQB: NWBO) Finally Catching the Attention of Investors with Advancement of Cancer Therapy?

While shares of Northwest Biotherapeutics (OTCQB: NWBO) haven’t quite reached the same levels they were at a year ago it appears as if investors are encouraged by the recent advancements the biotechnology company has made and trading activity has reflected … Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Leave a comment

Exelixis, Inc. (NASDAQ: EXEL) Remains a Big Risk Big Reward Biotech with Everything Riding on Cancer Drug Cabozantinib

It’s possible that the climb back north may have started for Exelixis, Inc. (NASDAQ: EXEL) as the biotechnology company is now in recovery mode following yesterday’s poor performance. On Wednesday shares of EXEL sank as low as  4.27 as investors … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , , , | Leave a comment

Will Latest News Prove Beneficial for Pluristem Therapeutics (NASDAQ: PSTI) and their FDA Efforts?

Less than a month ago shares of Pluristem Therapeutics (NASDAQ: PSTI) were trading as low as 2.38 but with news released on Monday that the company’s placenta-derived stem cell therapy had helped restore bone-marrow function in a 54-year-old patient suffering … Continue reading

Posted in Articles, NASDAQ | Tagged , , , , , , , , | Leave a comment